1492 Capital Management LLC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 87 filers reported holding CASI PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
1492 Capital Management LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$94,000
-24.2%
78,762
-1.2%
0.05%
-23.8%
Q2 2021$124,000
-67.5%
79,743
-50.0%
0.06%
-42.7%
Q1 2021$382,000159,4860.11%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$19,136,00025.80%
Consonance Capital Management LP 10,540,715$25,298,0002.70%
Wellington Shields & Co., LLC 1,832,769$4,399,0001.58%
Tri Locum Partners LP 1,500,000$3,600,0000.89%
Wellington Shields Capital Management, LLC 2,231,765$5,356,0000.51%
Ghost Tree Capital, LLC 650,000$1,560,0000.37%
1492 Capital Management LLC 159,486$382,0000.11%
Ikarian Capital, LLC 1,268,154$3,044,0000.10%
Sio Capital Management, LLC 203,432$488,0000.10%
Aristides Capital LLC 63,250$152,0000.06%
View complete list of CASI PHARMACEUTICALS INC shareholders